Condition
Absence Seizures
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06310772Completed
Assessing Comorbidities in Epilepsy Using Eye Movement Recordings
NCT06093490Completed
Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
NCT04439656Completed
Detecting Absence Seizures Using Eye Tracking
NCT04615442Not ApplicableCompletedPrimary
ECV - Epihunter Clinical Validation
NCT00545012Phase 2CompletedPrimary
A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
Showing all 5 trials